CEG•November 11, 2026 at 5:51 PM UTCUtilities

Constellation's Q3 Beat Underscores Base Strength, but Structural Catalysts Remain Unproven

Read source article

What happened

Constellation Energy reported a 66% jump in third-quarter adjusted earnings to $5.06 per share on $9.55 billion in revenue, confirming strong base operations and PTC benefits. The company's Q2 2026 10-Q had already shown improving fundamentals, but the master report maintained a WAIT rating at $266.60 due to high valuation (25.9x trailing EPS, 23.8x EV/EBITDA) and unresolved catalysts. The key issues remain cumulative nuclear PPAs stuck at 920 MW (needs >1.5 GW), the Q4 Illinois uprate filing still pending, and Crane's PJM interconnection contingent on upgrades possibly delayed to 2030. While the earnings beat supports near-term downside protection, it does not prove the premium contracting franchise can scale beyond Microsoft, Meta, and Walmart. The stock needs to trade below $235 to offer a compelling entry or show clear milestone progress before the thesis shifts.

Implication

Investors should not chase the rebound yet. The strong Q3 result confirms the PTC-supported base business is performing, but adjusted earnings alone do not resolve the three critical tests: additional nuclear PPAs, on-time Illinois uprate filing, and Crane interconnection certainty. At 25.9x trailing EPS and 23.8x EV/EBITDA, the stock already prices in significant premium contracting and restart optionality that management itself frames as 2029 upside rather than base earnings. A better entry below $235 would provide margin of safety, or a catalyst such as >1.5 GW cumulative new PPAs and a filed uprate application by Q1 2027 would justify adding exposure. Until then, maintain exposure only at lower prices or after visible milestone conversion.

Thesis delta

The Q3 earnings beat reinforces the thesis's base-case floor and does not alter the WAIT rating. The central premise remains unchanged: Constellation's moat is real, but equity upside depends on converting scarce nuclear capacity into long-duration contracts and clearing regulatory milestones, not just on PTC-supported earnings. No new information in the article addresses additional PPAs, uprate timing, or Crane deliverability, so conviction stays at 3.5 with a re-assessment window of 3-6 months.

Confidence

Medium